285 related articles for article (PubMed ID: 20452636)
1. Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer.
Pomerri F; Pucciarelli S; Maretto I; Zandonà M; Del Bianco P; Amadio L; Rugge M; Nitti D; Muzzio PC
Surgery; 2011 Jan; 149(1):56-64. PubMed ID: 20452636
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer.
Suppiah A; Hunter IA; Cowley J; Garimella V; Cast J; Hartley JE; Monson JR
Colorectal Dis; 2009 Mar; 11(3):249-53. PubMed ID: 18513192
[TBL] [Abstract][Full Text] [Related]
3. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer.
Maretto I; Pomerri F; Pucciarelli S; Mescoli C; Belluco E; Burzi S; Rugge M; Muzzio PC; Nitti D
Ann Surg Oncol; 2007 Feb; 14(2):455-61. PubMed ID: 17139456
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
6. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status.
Kulkarni T; Gollins S; Maw A; Hobson P; Byrne R; Widdowson D
Colorectal Dis; 2008 Jun; 10(5):479-89. PubMed ID: 18318754
[TBL] [Abstract][Full Text] [Related]
8. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
Kim TH; Chang HJ; Kim DY; Jung KH; Hong YS; Kim SY; Park JW; Oh JH; Lim SB; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1158-65. PubMed ID: 19800178
[TBL] [Abstract][Full Text] [Related]
9. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
10. [Comparative diagnosis of locally advanced rectal carcinoma after preoperative therapy].
Barth C; Rau B; Hünerbein M; Schlag PM
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1404-7. PubMed ID: 9931895
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
Read TE; Andujar JE; Caushaj PF; Johnston DR; Dietz DW; Myerson RJ; Fleshman JW; Birnbaum EH; Mutch MG; Kodner IJ
Dis Colon Rectum; 2004 Jun; 47(6):825-31. PubMed ID: 15108025
[TBL] [Abstract][Full Text] [Related]
12. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of magnetic resonance imaging in rectal cancer depends on location of the tumor.
Peschaud F; Cuenod CA; Benoist S; Julié C; Beauchet A; Siauve N; Taieb-Kasbi F; Penna C; Nordlinger B
Dis Colon Rectum; 2005 Aug; 48(8):1603-9. PubMed ID: 15937629
[TBL] [Abstract][Full Text] [Related]
14. Complete pathologic response after preoperative rectal cancer chemoradiotherapy.
Ciccocioppo A; Stephens JH; Hewett PJ; Rieger NA
ANZ J Surg; 2009 Jun; 79(6):481-4. PubMed ID: 19566874
[TBL] [Abstract][Full Text] [Related]
15. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
16. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Saltz LB; Goodman KA; Minsky BD; Wong WD; Weiser MR
Cancer; 2008 Jul; 113(1):57-64. PubMed ID: 18442099
[TBL] [Abstract][Full Text] [Related]
17. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Kim SH; Lee JM; Park HS; Eun HW; Han JK; Choi BI
J Magn Reson Imaging; 2009 May; 29(5):1093-101. PubMed ID: 19388124
[TBL] [Abstract][Full Text] [Related]
19. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
Yu SK; Tait D; Chau I; Brown G
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
[TBL] [Abstract][Full Text] [Related]
20. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
Mawdsley S; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Osborne M; Livingstone JI; MacDonald P; Mitchell IC; Meyrick-Thomas J; Northover JM; Windsor A; Novell R; Wallace M
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):745-52. PubMed ID: 16199310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]